創薬アウトソーシングの世界市場レポート 2025年

創薬アウトソーシング市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.8％で57億2,000万米ドルに成長します。予測期間の成長は、研究開発費の増加、特許失効、バイオ医薬品セクターの拡大、コアコンピタンスへの注力、市場投入までの時間短縮への圧力などに起因すると考えられます。予測期間における主な動向としては、人工知能の採用、技術の進歩、ビッグデータ分析、特殊医薬品、提携・戦略的パートナーシップなどが挙げられます。

慢性疾患の有病率の増加は、創薬アウトソーシング市場の成長を促進する可能性が高いです。高齢化、ライフスタイルの選択、都市化、環境の影響などの要因により、数年または生涯にわたって持続する長期的な健康状態である慢性疾患が一般的になりつつあります。創薬のアウトソーシングは、専門的な知識や高度な技術へのアクセスを提供することで、慢性疾患の治療開発を迅速化し、時間とコストを削減するのに役立ちます。例えば、2024年6月、オーストラリア保健福祉研究所（Australian Institute of Health and Welfare）は、オーストラリア人口の61％、約1,540万人が少なくとも1つの長期的健康状態にあり、2022年の死亡原因の90％を占めていると報告しました。不安のような症状は、0～24歳の130万人（16％）、25～44歳の160万人（22％）に影響を与えました。腰痛は45～64歳の150万人（23％）に見られ、65歳以上の130万人（32％）が聴覚障害や難聴を経験しています。このような慢性疾患の有病率の上昇が、創薬アウトソーシング市場の成長を後押ししています。

創薬アウトソーシング分野の企業は、ヘルスケア専門家、規制当局、患者により良いサービスを提供するため、デジタルヘルスソリューションなどのイノベーションに注力しています。デジタルヘルスソリューションには、ヘルスケア提供、患者エンゲージメント、健康管理を改善する遠隔医療、モバイルヘルスアプリ、ウェアラブルデバイスなどの技術やサービスが含まれます。例えば、2023年11月、英国のバイオ製薬会社であるアストラゼネカPLCは、ライフサイエンス・イノベーションの推進と臨床試験デリバリーの改善を目的としたヘルステック事業であるEvinovaを発表しました。Evinovaは、40カ国以上に及ぶアストラゼネカの臨床試験で有効性が実証された世界なデジタル製品とサービスに焦点を当てています。臨床試験のデザインと実施を強化することで、Evinovaは新薬開発を合理化し、時間とコストの両方を削減することを目指しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界創薬アウトソーシング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の創薬アウトソーシング市場：成長率分析
• 世界の創薬アウトソーシング市場の実績：規模と成長, 2019-2024
• 世界の創薬アウトソーシング市場の予測：規模と成長, 2024-2029, 2034F
• 世界創薬アウトソーシング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の創薬アウトソーシング市場：サービスタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学サービス
• 生物学的サービス
• 世界の創薬アウトソーシング市場：ワークフロー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ターゲットの特定とスクリーニング
• ターゲット検証と機能情報科学
• リード特定と候補者最適化
• 前臨床開発
• その他のワークフロー
• 世界の創薬アウトソーシング市場疾患モデル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• インビトロモデル
• 動物モデル
• 細胞モデル
• その他の疾患モデル
• 世界の創薬アウトソーシング市場治療領域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心血管系
• 中枢神経系（CNS）
• 胃腸
• 血液学
• 呼吸器系
• 感染症
• 腫瘍学
• 免疫学
• その他の治療領域
• 世界の創薬アウトソーシング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー企業
• 学術機関
• その他のエンドユーザー
• 世界の創薬アウトソーシング市場化学サービスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• カスタム合成および製造
• 医薬品化学
• コンビナトリアルケミストリー
• ヒットの特定とリードの最適化
• プロセス化学とスケールアップ
• 分析化学サービス
• 化学ライブラリの設計とスクリーニング
• ADMET（吸収、流通、代謝、排泄、毒性）プロファイリング
• 世界の創薬アウトソーシング市場、生物学的サービスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞ベースのアッセイとスクリーニング
• ターゲットの識別と検証
• 体外試験および生体内試験
• バイオマーカーの発見と開発
• 毒性学研究
• ゲノミクスおよびプロテオミクスサービス
• 前臨床開発のための動物モデル
• 生物学的安全性および有効性試験
• バイオ医薬品の開発と製造

第7章 地域別・国別分析

• 世界の創薬アウトソーシング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の創薬アウトソーシング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 創薬アウトソーシング市場：競合情勢
• 創薬アウトソーシング市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins SE Overview, Products and Services, Strategy and Financial Analysis
  • Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • QIAGEN N.V. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Curia Global Inc.
• EVOTEC
• Pharmaron Beijing Co. Ltd.
• Genscript Biotech
• WuXi AppTec
• Pharmaceutical Product Development, LLC
• Syngene International Limited
• Jubilant Biosys
• Dalton Pharma Services
• Oncodesign Services
• DiscoverX Corp.
• Domainex Ltd.
• Exscientia
• TCG Lifesciences Pvt Ltd.
• GVK Biosciences Private Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 創薬アウトソーシング市場2029：新たな機会を提供する国
• 創薬アウトソーシング市場2029：新たな機会を提供するセグメント
• 創薬アウトソーシング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Drug discovery outsourcing involves pharmaceutical companies contracting external organizations to handle various stages of the drug discovery process, such as target identification, lead optimization, and preclinical testing. This practice leverages specialized expertise, reduces costs, and speeds up development timelines.

The main types of drug discovery outsourcing include chemistry services and biological services. Chemistry services encompass specialized chemical expertise, including the synthesis, analysis, and optimization of drug candidates. The workflow typically involves target identification and screening, target validation and functional informatics, lead identification and candidate optimization, and preclinical development. Disease models used in these services include in vitro models, animal models, and cellular models. These services cater to various therapeutic areas, such as cardiovascular, central nervous system (CNS), gastrointestinal, hematology, respiratory, infectious diseases, oncology, immunology, and more. End users include pharmaceutical and biotechnology companies, academic institutions, and other organizations.

The drug discovery outsourcing market research report is one of a series of new reports from The Business Research Company that provides drug discovery outsourcing market statistics, including the drug discovery outsourcing industry's global market size, regional shares, competitors with a drug discovery outsourcing market share, detailed drug discovery outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery outsourcing industry. This drug discovery outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The drug discovery outsourcing market size has grown strongly in recent years. It will grow from $3.92 $ billion in 2024 to $4.24 $ billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to the growing complexity of drug discovery, the need for specialized expertise, stringent regulatory requirements, the globalization of clinical trials, and the rise in demand for orphan drugs and personalized medicine.

The drug discovery outsourcing market size is expected to see strong growth in the next few years. It will grow to $5.72 $ billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing expenses in research and development, patent expirations, the expansion of the biopharmaceutical sector, focus on core competencies, and pressure to reduce time-to-market. Major trends in the forecast period include the adoption of artificial intelligence, technological advancements, big data analytics, specialty drugs, and collaboration and strategic partnerships.

The increasing prevalence of chronic diseases is likely to drive the growth of the drug discovery outsourcing market. Chronic diseases, which are long-term health conditions that can persist for years or a lifetime, are becoming more common due to factors such as an aging population, lifestyle choices, urbanization, and environmental influences. Outsourcing drug discovery helps expedite the development of treatments for chronic diseases by providing access to specialized expertise and advanced technologies, thereby reducing time and costs. For example, in June 2024, the Australian Institute of Health and Welfare reported that 61% of the Australian population, about 15.4 million people, had at least one long-term health condition, which contributed to 90% of deaths in 2022. Conditions like anxiety affected 1.3 million (16%) of individuals aged 0-24 and 1.6 million (22%) of those aged 25-44. Back problems were noted in 1.5 million (23%) of people aged 45-64, and 1.3 million (32%) of individuals aged 65 and older experienced deafness or hearing loss. This rising prevalence of chronic diseases is fueling growth in the drug discovery outsourcing market.

Companies in the drug discovery outsourcing sector are focusing on innovations such as digital health solutions to better serve healthcare professionals, regulators, and patients. Digital health solutions include technologies and services like telemedicine, mobile health apps, and wearable devices that improve healthcare delivery, patient engagement, and health management. For instance, in November 2023, AstraZeneca PLC, a UK-based biopharmaceutical company, introduced Evinova, a health-tech business aimed at advancing life sciences innovation and improving clinical trial delivery. Evinova focuses on global digital products and services that have demonstrated effectiveness in AstraZeneca's clinical trials across more than 40 countries. By enhancing clinical trial design and execution, Evinova aims to streamline new medicine development, reducing both time and costs.

In July 2024, Selvita SA, a Poland-based company specializing in drug discovery, research, and development services, acquired PozLab for an undisclosed sum. This acquisition strengthens Selvita's capabilities in drug development, positioning the company as a comprehensive solution provider in the pharmaceutical industry and expanding its offerings to include small molecule drug manufacturing services for early-stage clinical trials. PozLab is a Poland-based contract development organization that provides end-to-end pharmaceutical development services.

Major companies operating in the drug discovery outsourcing market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins SE, Charles River Laboratories, QIAGEN N.V., Curia Global Inc., EVOTEC, Pharmaron Beijing Co. Ltd., Genscript Biotech, WuXi AppTec, Pharmaceutical Product Development, LLC, Syngene International Limited, Jubilant Biosys, Dalton Pharma Services, Oncodesign Services, DiscoverX Corp., Domainex Ltd., Exscientia, TCG Lifesciences Pvt Ltd., GVK Biosciences Private Limited

North America was the largest region in the drug discovery outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug discovery outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug discovery outsourcing market includes revenues earned by entities by providing services such as trial design, site management, patient recruitment, and data collection and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Discovery Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug discovery outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug discovery outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug discovery outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service Type: Chemistry Services; Biological Services
• 2) By Workflow: Target Identification And Screening; Target Validation And Functional Informatics; Lead Identification And Candidate Optimization; Preclinical Development; Other Workflows
• 3) By Disease Model: In Vitro Models; Animal Models; Cellular Models; Other Disease Models
• 4) By Therapeutic Area: Cardiovascular; Central Nervous System (CNS); Gastrointestinal; Hematology; Respiratory System; Infectious Disease; Oncology; Immunology; Other Therapeutic Areas
• 5) By End User: Pharmaceutical And Biotechnology Companies; Academic Institutes; Other End Users
• Subsegments:
• 1) By Chemistry Services: Custom Synthesis And Manufacturing; Medicinal Chemistry; Combinatorial Chemistry; Hit Identification And Lead Optimization; Process Chemistry And Scale-Up; Analytical Chemistry Services; Chemical Library Design And Screening; ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Profiling
• 2) By Biological Services: Cell-Based Assays And Screening; Target Identification And Validation; In Vitro And In Vivo Testing; Biomarker Discovery And Development; Toxicology Studies; Genomics And Proteomics Services; Animal Models For Preclinical Development; Biological Safety And Efficacy Testing; Biopharmaceutical Development And Manufacturing.
• Companies Mentioned: Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Eurofins SE; Charles River Laboratories; QIAGEN N.V.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Discovery Outsourcing Market Characteristics

3. Drug Discovery Outsourcing Market Trends And Strategies

4. Drug Discovery Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Drug Discovery Outsourcing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Drug Discovery Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Drug Discovery Outsourcing Market Growth Rate Analysis
• 5.4. Global Drug Discovery Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Drug Discovery Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Drug Discovery Outsourcing Total Addressable Market (TAM)

6. Drug Discovery Outsourcing Market Segmentation

• 6.1. Global Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemistry Services
• Biological Services
• 6.2. Global Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Target Identification And Screening
• Target Validation And Functional Informatics
• Lead Identification And Candidate Optimization
• Preclinical Development
• Other Workflows
• 6.3. Global Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In Vitro Models
• Animal Models
• Cellular Models
• Other Disease Models
• 6.4. Global Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular
• Central Nervous System (CNS)
• Gastrointestinal
• Hematology
• Respiratory System
• Infectious Disease
• Oncology
• Immunology
• Other Therapeutic Areas
• 6.5. Global Drug Discovery Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Academic Institutes
• Other End Users
• 6.6. Global Drug Discovery Outsourcing Market, Sub-Segmentation Of Chemistry Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Custom Synthesis And Manufacturing
• Medicinal Chemistry
• Combinatorial Chemistry
• Hit Identification And Lead Optimization
• Process Chemistry And Scale-Up
• Analytical Chemistry Services
• Chemical Library Design And Screening
• ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Profiling
• 6.7. Global Drug Discovery Outsourcing Market, Sub-Segmentation Of Biological Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell-Based Assays And Screening
• Target Identification And Validation
• In Vitro And In Vivo Testing
• Biomarker Discovery And Development
• Toxicology Studies
• Genomics And Proteomics Services
• Animal Models For Preclinical Development
• Biological Safety And Efficacy Testing
• Biopharmaceutical Development And Manufacturing

7. Drug Discovery Outsourcing Market Regional And Country Analysis

• 7.1. Global Drug Discovery Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Drug Discovery Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Discovery Outsourcing Market

• 8.1. Asia-Pacific Drug Discovery Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Discovery Outsourcing Market

• 9.1. China Drug Discovery Outsourcing Market Overview
• 9.2. China Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Discovery Outsourcing Market

• 10.1. India Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Discovery Outsourcing Market

• 11.1. Japan Drug Discovery Outsourcing Market Overview
• 11.2. Japan Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Discovery Outsourcing Market

• 12.1. Australia Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Discovery Outsourcing Market

• 13.1. Indonesia Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Discovery Outsourcing Market

• 14.1. South Korea Drug Discovery Outsourcing Market Overview
• 14.2. South Korea Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Discovery Outsourcing Market

• 15.1. Western Europe Drug Discovery Outsourcing Market Overview
• 15.2. Western Europe Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Discovery Outsourcing Market

• 16.1. UK Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Discovery Outsourcing Market

• 17.1. Germany Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Discovery Outsourcing Market

• 18.1. France Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Discovery Outsourcing Market

• 19.1. Italy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Discovery Outsourcing Market

• 20.1. Spain Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Discovery Outsourcing Market

• 21.1. Eastern Europe Drug Discovery Outsourcing Market Overview
• 21.2. Eastern Europe Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Discovery Outsourcing Market

• 22.1. Russia Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Discovery Outsourcing Market

• 23.1. North America Drug Discovery Outsourcing Market Overview
• 23.2. North America Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Discovery Outsourcing Market

• 24.1. USA Drug Discovery Outsourcing Market Overview
• 24.2. USA Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Discovery Outsourcing Market

• 25.1. Canada Drug Discovery Outsourcing Market Overview
• 25.2. Canada Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Discovery Outsourcing Market

• 26.1. South America Drug Discovery Outsourcing Market Overview
• 26.2. South America Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Discovery Outsourcing Market

• 27.1. Brazil Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Discovery Outsourcing Market

• 28.1. Middle East Drug Discovery Outsourcing Market Overview
• 28.2. Middle East Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Discovery Outsourcing Market

• 29.1. Africa Drug Discovery Outsourcing Market Overview
• 29.2. Africa Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Discovery Outsourcing Market Competitive Landscape And Company Profiles

• 30.1. Drug Discovery Outsourcing Market Competitive Landscape
• 30.2. Drug Discovery Outsourcing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eurofins SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. QIAGEN N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Drug Discovery Outsourcing Market Other Major And Innovative Companies

• 31.1. Curia Global Inc.
• 31.2. EVOTEC
• 31.3. Pharmaron Beijing Co. Ltd.
• 31.4. Genscript Biotech
• 31.5. WuXi AppTec
• 31.6. Pharmaceutical Product Development, LLC
• 31.7. Syngene International Limited
• 31.8. Jubilant Biosys
• 31.9. Dalton Pharma Services
• 31.10. Oncodesign Services
• 31.11. DiscoverX Corp.
• 31.12. Domainex Ltd.
• 31.13. Exscientia
• 31.14. TCG Lifesciences Pvt Ltd.
• 31.15. GVK Biosciences Private Limited

32. Global Drug Discovery Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Discovery Outsourcing Market

34. Recent Developments In The Drug Discovery Outsourcing Market

35. Drug Discovery Outsourcing Market High Potential Countries, Segments and Strategies

• 35.1 Drug Discovery Outsourcing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Drug Discovery Outsourcing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Drug Discovery Outsourcing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer